Our website uses cookies to make navigation as functional as possible. Our cookies do not enable us to identify you in any way. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here to disable them. By continuing to browse this site , you will be accepting our cookies.

Respiratory

Product Name Active Ingredient/
Generic Name
Presentations Available Patient
Information
Eklira Genuair Aclidinium bromide 322 micrograms inhalation powder
Brimica Genuair Aclidinium / Formoterol fumarate dihydrate 340 micrograms /12 micrograms inhalation powder

 

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the patient leaflet. You can also report side effects directly to: HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2, Tel: +353 1 6764971, Fax:+353 1 6762517, Website: www.hpra.ie, email:medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.

Quality first


Quality: point of departure and arrival for our drugs.

READ MORE »

Menarini in the world

The Menarini Group has companies located almost all over the world.

READ MORE »

Innovation & Research

Constant commitment to new drug research.

READ MORE »

Our values

 

10 core values have influenced the progress of our group.

READ MORE »